CIK: 0001637359
Total reported value
$163.1M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | REPL | Replimune Group INC | Stock-Other | 21.86% | +0.33% | — | |
| 2 | MORFUSD | Morphic Holding INC | Stock-Other | 18.04% | — | — | |
| 3 | GOSS | Gossamer Bio INC | Stock-Other | 17.96% | — | -30.13% | |
| 4 | ARQT | Arcutis Biotherapeutics INC | Stock-Other | 10.42% | — | — | |
| 5 | ✓ | Translate Bio INC | Stock-Other | 10.06% | — | — | |
| 6 | VTLUSD | Immunic INC | Stock-Other | 3.43% | — | — | |
| 7 | PRTKEUR | Paratek Pharmaceuticals INC | Stock-Other | 3.39% | — | — | |
| 8 | EPIEUR | Essa Pharma INC | Stock-Other | 2.80% | — | -1.17% | |
| 9 | BEAM | Beam Therapeutics INC | Stock-Other | 2.26% | — | — | |
| 10 | ✓ | Cidara Therapeutics INC Com New | Stock-Other | 2.06% | — | +22.41% | |
| 11 | FGENEUR | Fibrogen INC | Stock-Other | 1.88% | — | — | |
| 12 | TRVI | Trevi Therapeutics INC | Stock-Other | 1.72% | — | — | |
| 13 | ✓ | Prevail Therapeutics INC | Stock-Other | 1.38% | — | -59.22% | |
| 14 | JNCEEUR | Jounce Therapeutics INC | Stock-Other | 1.04% | — | — | |
| 15 | ✓ | Obseva SA | Stock-Other | 1.00% | — | — | |
| 16 | PIRSEUR | Pieris Pharmaceuticals INC | Stock-Other | 0.71% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ✓ | Translate Bio INC | +3.7% | — | Unchanged |
| 2 | MORFUSD | Morphic Holding INC | +1.8% | — | Unchanged |
| 3 | TRVI | Trevi Therapeutics INC | +0.2% | — | Unchanged |
| 4 | FGENEUR | Fibrogen INC | +0.1% | — | Unchanged |
| 5 | PRTKEUR | Paratek Pharmaceuticals INC | +0.1% | — | Unchanged |
| 6 | ✓ | Cidara Therapeutics INC Com New | +0.1% | +22.41% | Add |
| 7 | PIRSEUR | Pieris Pharmaceuticals INC | -0.2% | — | Unchanged |
| 8 | EPIEUR | Essa Pharma INC | -0.2% | -1.17% | Trim |
| 9 | ✓ | Obseva SA | -0.2% | — | Unchanged |
| 10 | JNCEEUR | Jounce Therapeutics INC | -0.4% | — | Unchanged |
| 11 | VTLUSD | Immunic INC | -0.8% | — | Unchanged |
| 12 | ✓ | Prevail Therapeutics INC | -2% | -59.22% | Trim |
| 13 | REPL | Replimune Group INC | -2.4% | — | Unchanged |
| 14 | GOSS | Gossamer Bio INC | -12.5% | -30.13% | Trim |
| 15 | ARQT | Arcutis Biotherapeutics INC | — | NEW | New buy |
| 16 | BEAM | Beam Therapeutics INC | — | NEW | New buy |